FDA Strengthens Warnings Feraheme
Anemia Drug Feraheme Allergic Reactions. The Food and Drug Administration (FDA) is strengthening the existing warning about serious, potentially fatal allergic reactions that can occur with the anemia drug Feraheme (ferumoxytol). The agency FDA changed the prescribing instructions and approved a Boxed Warning—the FDA’s strongest type … [Read more...] about FDA Strengthens Warnings Feraheme
Amgen Ends Aranesp Marketing Practices
Amgen Ends Aranesp Marketing Practices. The maker of Aranesp is halting marketing practices that critics said encouraged over-use of the anemia drug. Criticism of the policies, in which Amgen paid rebates to doctors for the purchase of Aranesp, had grown along with questions about the drug's safety. Aranesp is an … [Read more...] about Amgen Ends Aranesp Marketing Practices
J&J To Add Warning To Drug
J&J Add Warning To Drug Label. Johnson & Johnson said Monday that it asked European regulators to add a warning to the label of its biotech anemia drug, a move that could benefit a rival product from Amgen Inc. J&J said that the label should warn kidney disease patients not to take Eprex by injection into the … [Read more...] about J&J To Add Warning To Drug
